SysteMHC v.231201
Home Datasets Download Help About Update

Showing details for project SYSMHC00006



SampleID NumReplicates Organism TissueType CellType MHCAllele
SampleID NumReplicates Organism TissueType CellType MHCAllele
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_IEF 36 Human HLA-A02_01,HLA-B07_02,HLA-B44_02,HLA-C05_01,HLA-C07_02
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX 48 Human HLA-A02_01,HLA-B07_02,HLA-B44_02,HLA-C05_01,HLA-C07_02
SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 44 Human HLA-A02_01,HLA-B07_02,HLA-C07_02
SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_IEF 24 Human HLA-A02_01,HLA-B07_02,HLA-C07_02
SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_SCX 36 Human HLA-A02_01,HLA-B07_02,HLA-C07_02



Detailed view of sample SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18



ID SampleID RawFileName Organism Process Tissue Type Cell Type Culture Conditions Disease State Comments MHCClass MHCAllele PubMed ID Peptide Isolation Method Antibody Mass Spectrometer LC System iRT Peptides Acquisition Mode Fragmentation Method Gradient Gradient Length Flow Rate Replicate Number
ID SampleID RawFileName Organism Process Tissue_Type Cell_Type Culture_Conditions Disease_State Comments MHCClass MHCAllele PubMed_ID Peptide Isolation_Method Antibody Mass_Spectrometer LC_System iRT_Peptides Acquisition_Mode Fragmentation_Method Gradient Gradient_Length Flow_Rate Replicate_Number
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292321a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 1
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292322a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 2
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292323a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 3
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292324a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 4
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292325a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 5
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292326a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 6
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292327a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 7
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292328a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 8
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292329a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 9
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292307a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 10
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292331a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 11
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292333a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 12
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292334a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 13
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292335a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 14
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292336a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 15
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292337a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 16
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292338a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 17
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292339a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 18
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292340a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 19
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292320a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 20
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292330a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 21
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292319a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 22
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292305a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 23
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292317a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 24
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292318a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 25
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292296a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 26
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292297a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 27
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292298a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 28
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292299a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 29
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292300a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 30
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292302a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 31
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292303a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 32
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292304a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 33
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292301a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 34
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292308a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 35
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292309a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 36
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292310a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 37
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292311a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 38
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292312a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 39
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292313a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 40
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292314a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 41
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292315a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 42
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292306a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 43
SYSMHC00006 SYSMHC00006_hassanc_160817_vanveelen_netherlands_JY_C18 SYSMHC00006_s292316a.RAW Human In vitro Blood JY suspension JY C18 class I HLA-A02_01,HLA-B07_02,HLA-C07_02 23481700 native Immunoaffinity W6/32 LTQ-FT Agilent 1100 plus flowsplitter no DDA CID 0-50%B 120 5 um id 15 cm 44